Publication | Closed Access
Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma
33
Citations
32
References
2020
Year
Immune Checkpoint InhibitorsMelanomaImmunologyMonoclonal Antibody D16f7Immune Checkpoint InhibitorCutaneous MelanomaDermatologyImmunotherapyMedicineTumor MicroenvironmentSkin Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1